Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma

Experimental Hematology

Volumn 36, Issue 12, 2008, Pages

  Tshuikina, Marina ^a   Jernberg Wiklund, Helena ^a   Nilsson, Kenneth ^a   Öberg, Fredrik ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 4; INTERFERON REGULATORY FACTOR 5; INTERFERON REGULATORY FACTOR 6; INTERFERON REGULATORY FACTOR 7; INTERFERON REGULATORY FACTOR 9; SYNDECAN 1;

ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 55549112534     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.08.001     Document Type: Article

References (44)

1. Hallek M., Bergsagel P.L., and Anderson K.C. Multiple myeloma: increasing evidence for a multistep transformation process. Blood 91 (1998) 3-21
2. Bergsagel P.L., and Kuehl W.M. Chromosome translocations in multiple myeloma. Oncogene 20 (2001) 5611-5622
3. Ng M.H., Chung Y.F., Lo K.W., Wickham N.W., Lee J.C., and Huang D.P. Frequent hypermethylation of p16 and p15 genes in multiple myeloma. Blood 89 (1997) 2500-2506
4. Katzenellenbogen R.A., Baylin S.B., and Herman J.G. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 93 (1999) 4347-4353
5. Galm O., Yoshikawa H., Esteller M., Osieka R., and Herman J.G. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 101 (2003) 2784-2788
6. Chim C.S., Pang R., Fung T.K., Choi C.L., and Liang R. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma. Leukemia 21 (2007) 2527-2536
7. Nguyen H., Hiscott J., and Pitha P.M. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev. 8 (1997) 293-312
8. Mamane Y., Heylbroeck C., Genin P., et al. Interferon regulatory factors: the next generation. Gene 237 (1999) 1-14
9. Lu R., Medina K.L., Lancki D.W., and Singh H. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 17 (2003) 1703-1708
10. Klein U., Casola S., Cattoretti G., et al. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 7 (2006) 773-782
11. Iida S., Rao P.H., Butler M., et al. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet. 17 (1997) 226-230
12. Holtschke T., Lohler J., Kanno Y., et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87 (1996) 307-317
13. Schmidt M., Nagel S., Proba J., et al. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood 91 (1998) 22-29
14. Arguello M., Sgarbanti M., Hernandez E., et al. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. Oncogene 22 (2003) 964-973
15. Lee C.H., Melchers M., Wang H., et al. Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J Exp Med 203 (2006) 63-72
16. Yang D., Thangaraju M., Greeneltch K., et al. Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells. Cancer Res. 67 (2007) 3301-3309
17. Gabriele L., Phung J., Fukumoto J., et al. Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein. J Exp Med 190 (1999) 411-421
18. Nilsson K., Bennich H., Johansson S.G., and Ponten J. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol 7 (1970) 477-489
19. Jernberg-Wiklund H., and Nilsson K. Multiple myeloma cell lines. In: Palsson J.R.W. (Ed). Human Cell Culture vol. 3 (2000), Multiple myeloma cell lines, Dordrecht/Boston/London 81-156
20. Karpas A., Fisher P., and Swirsky D. Human plasmacytoma with an unusual karyotype growing in vitro and producing light-chain immunoglobulin. Lancet 1 8278 (1982) 931-933
21. Scibienski R.J., Paglieroni T.G., and MacKenzie M.R. Establishment and characterization of a CD5 positive, immunosuppressive human myeloma cell line. Leukemia 4 (1990) 775-780
22. Scibienski R.J., Paglieroni T., Caggiano V., Lemongello D., Gumerlock P.H., and Mackenzie M.R. Factors affecting the in vitro evolution of a myeloma cell line. Leukemia 6 (1992) 940-947
23. Diehl V., Schaadt M., Kirchner H., et al. Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: a comparative study. Blut 36 (1978) 331-338
24. Kubonishi I., Seto M., Shimamura T., Enzan H., and Miyoshi I. The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia. Cancer 70 (1992) 1528-1535
25. Pegoraro L., Malavasi F., Bellone G., et al. The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation. Blood 73 (1989) 1020-1027
26. Matsuoka Y., Moore G.E., Yagi Y., and Pressman D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med 125 (1967) 1246-1250
27. Sundstrom C., and Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17 (1976) 565-577
28. Gillis S., and Watson J. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J Exp Med 152 (1980) 1709-1719
29. Menezes J., Leibold W., Klein G., and Clements G. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine 22 (1975) 276-284
30. Kohno S., Minowada J., and Sandberg A.A. Chromosome evolution of near-haploid clones in an established human acute lymphoblastic leukemia cell line (NALM-16). J Natl Cancer Inst 64 (1980) 485-493
31. Matsuo Y., and Drexler H.G. Establishment and characterization of human B cell precursor-leukemia cell lines. Leuk Res. 22 (1998) 567-579
32. Muraguchi A., Kishimoto T., Miki Y., et al. T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. J Immunol 127 (1981) 412-416
33. Nilsson K., and Klein G. Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. Adv Cancer Res. 37 (1982) 319-380
34. Dimberg A., Karehed K., Nilsson K., and Oberg F. Inhibition of monocytic differentiation by phosphorylation-deficient Stat1 is associated with impaired expression of Stat2, ICSBP/IRF8 and C/EBPepsilon. Scand J Immunol 64 (2006) 271-279
35. Rhodes D.R., Yu J., Shanker K., et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6 (2004) 1-6
36. Zhan F., Hardin J., Kordsmeier B., et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 99 (2002) 1745-1757
37. Driggers P.H., Ennist D.L., Gleason S.L., et al. An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 87 (1990) 3743-3747
38. Feinberg A.P., Ohlsson R., and Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet. 7 (2006) 21-33
39. Tarte K., Zhan F., De Vos J., Klein B., and Shaughnessy Jr. J. Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. Blood 102 (2003) 592-600
40. Ballestar E., and Wolffe A.P. Methyl-CpG-binding proteins. Targeting specific gene repression. Eur J Biochem 268 (2001) 1-6
41. Jernberg-Wiklund H., Pettersson M., Carlsson M., and Nilsson K. Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop. Leukemia 6 (1992) 310-318
42. Schlesinger Y., Straussman R., Keshet I., et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet. 39 (2007) 232-236
43. Ohm J.E., McGarvey K.M., Yu X., et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet. 39 (2007) 237-242
44. Cameron E.E., Bachman K.E., Myohanen S., Herman J.G., and Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet. 21 (1999) 103-107